BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23469288)

  • 21. Highly (H5N1) and low (H7N2) pathogenic avian influenza virus infection in falcons via nasochoanal route and ingestion of experimentally infected prey.
    Bertran K; Busquets N; Abad FX; García de la Fuente J; Solanes D; Cordón I; Costa T; Dolz R; Majó N
    PLoS One; 2012; 7(3):e32107. PubMed ID: 22427819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge.
    Shirvani E; Varghese BP; Paldurai A; Samal SK
    Sci Rep; 2020 Feb; 10(1):2221. PubMed ID: 32042001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination with recombinant RNA replicon particles protects chickens from H5N1 highly pathogenic avian influenza virus.
    Halbherr SJ; Brostoff T; Tippenhauer M; Locher S; Berger Rentsch M; Zimmer G
    PLoS One; 2013; 8(6):e66059. PubMed ID: 23762463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental infection of ostriches with H7N1 low pathogenic and H5N8 clade 2.3.4.4B highly pathogenic influenza A viruses.
    Abolnik C; Ostmann E; Woods M; Wandrag DBR; Grewar J; Roberts L; Olivier AJ
    Vet Microbiol; 2021 Dec; 263():109251. PubMed ID: 34656859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice.
    Cornelissen LA; de Leeuw OS; Tacken MG; Klos HC; de Vries RP; de Boer-Luijtze EA; van Zoelen-Bos DJ; Rigter A; Rottier PJ; Moormann RJ; de Haan CA
    PLoS One; 2012; 7(8):e44447. PubMed ID: 22952980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis and transmissibility of highly (H7N1) and low (H7N9) pathogenic avian influenza virus infection in red-legged partridge (Alectoris rufa).
    Bertran K; Pérez-Ramírez E; Busquets N; Dolz R; Ramis A; Darji A; Abad FX; Valle R; Chaves A; Vergara-Alert J; Barral M; Höfle U; Majó N
    Vet Res; 2011 Feb; 42(1):24. PubMed ID: 21314907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PB1-F2 attenuates virulence of highly pathogenic avian H5N1 influenza virus in chickens.
    Leymarie O; Embury-Hyatt C; Chevalier C; Jouneau L; Moroldo M; Da Costa B; Berhane Y; Delmas B; Weingartl HM; Le Goffic R
    PLoS One; 2014; 9(6):e100679. PubMed ID: 24959667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.
    Bertran K; Lee DH; Criado MF; Balzli CL; Killmaster LF; Kapczynski DR; Swayne DE
    Vaccine; 2018 Oct; 36(43):6361-6372. PubMed ID: 30241684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenicity evaluation of neuraminidase-negative H5 and H7 viruses in day-old chicks and adult chicken.
    Hoffmann D; Röhrs S; Rahn J; Stech J; Beer M
    Vaccine; 2015 Dec; 33(49):6997-7001. PubMed ID: 26469725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
    Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
    Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prime-boost immunization using a DNA vaccine delivered by attenuated Salmonella enterica serovar typhimurium and a killed vaccine completely protects chickens from H5N1 highly pathogenic avian influenza virus.
    Pan Z; Zhang X; Geng S; Fang Q; You M; Zhang L; Jiao X; Liu X
    Clin Vaccine Immunol; 2010 Apr; 17(4):518-23. PubMed ID: 20107004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental and Field Results Regarding Immunity Induced by a Recombinant Turkey Herpesvirus H5 Vector Vaccine Against H5N1 and Other H5 Highly Pathogenic Avian Influenza Virus Challenges.
    Gardin Y; Palya V; Dorsey KM; El-Attrache J; Bonfante F; Wit Sd; Kapczynski D; Kilany WH; Rauw F; Steensels M; Soejoedono RD
    Avian Dis; 2016 May; 60(1 Suppl):232-7. PubMed ID: 27309060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virus interference between H7N2 low pathogenic avian influenza virus and lentogenic Newcastle disease virus in experimental co-infections in chickens and turkeys.
    Costa-Hurtado M; Afonso CL; Miller PJ; Spackman E; Kapczynski DR; Swayne DE; Shepherd E; Smith D; Zsak A; Pantin-Jackwood M
    Vet Res; 2014 Jan; 45(1):1. PubMed ID: 24393488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of maternal immunity on vaccine efficacy and susceptibility of one day old chicks against Egyptian highly pathogenic avian influenza H5N1.
    Abdelwhab EM; Grund C; Aly MM; Beer M; Harder TC; Hafez HM
    Vet Microbiol; 2012 Feb; 155(1):13-20. PubMed ID: 21920677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial heterologous protection by low pathogenic H9N2 virus against natural H9N2-PB1 gene reassortant highly pathogenic H5N1 virus in chickens.
    Dash SK; Kumar M; Kataria JM; Nagarajan S; Tosh C; Murugkar HV; Kulkarni DD
    Microb Pathog; 2016 Jun; 95():157-165. PubMed ID: 27057675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of homologous and heterologous neuraminidase vaccines in chickens against H5N1 highly pathogenic avian influenza.
    Lee YJ; Sung HW; Choi JG; Lee EK; Jeong OM; Kwon YK; Kwon JH; Song CS; Kimd JH
    Avian Dis; 2007 Mar; 51(1 Suppl):476-8. PubMed ID: 17494612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coexpression of soluble and membrane-bound avian influenza virus H5 by recombinant Newcastle disease virus leads to an increase in antigen levels.
    Murr M; Karger A; Steglich C; Mettenleiter TC; Römer-Oberdörfer A
    J Gen Virol; 2020 May; 101(5):473-483. PubMed ID: 32209169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Bivalent Inactivated Vaccine Containing Insect Cell-Expressed Avian Influenza H5 and Egg-Based Newcastle Disease Virus (NDV) Against Dual Infection with Highly Pathogenic H5N1 and Velogenic NDV in Chickens.
    Said M; Soliman MA; Mousa S; Arafa A; Hussein HA; Amarin N; Mundt E
    Avian Dis; 2019 Sep; 63(3):474-480. PubMed ID: 31967431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
    Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
    Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of host genes linked with the survivability of chickens infected with recombinant viruses possessing H5N1 surface antigens from a highly pathogenic avian influenza virus.
    Uchida Y; Watanabe C; Takemae N; Hayashi T; Oka T; Ito T; Saito T
    J Virol; 2012 Mar; 86(5):2686-95. PubMed ID: 22190712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.